Newer GLP-1 medications, such as Ozempic and Manjero, are showing significant promise in weight loss, with studies indicating an average weight reduction of over 20% for those on Manjero. These medications not only aid in weight management but also provide cardiovascular benefits, making them a vital option for individuals at risk for heart disease. Comparatively, older treatments like Bayetta and Victoza fall short in weight loss effectiveness, highlighting the advancements in diabetes management.
